Survey Results and Discussion of Issues
On July 10, 2008, the Pharmaceutical Research and Manufacturers of America (PhRMA) Board of Directors adopted measures to enhance the PhRMA Code on Interactions with Healthcare Professionals. This Code, which may have a profound effect on how pharma-ceutical companies interact with physicians, became effective on January 1, 2009.
To better understand the impact of this code on the pharmaceutical industry, Pharma Marketing News
surveyed readers between July 10, 2008 and August 7, 2008, and collected comments from pharma-focused blogs and bulletin boards. This article is a summary of the PMN survey results and opinions of experts, bloggers, and anonymous commentators.
Topics and issues covered include:
- Survey Results
- Who Benefits from the New Code?
- Massachusetts Health Care Cost and Quality Act
- Free Gifts to Physicians
- What Sales Reps Have to Say
- Compliance is the Elephant in the Room
- PhRMA vs. ABPI: How Do the Codes Compare?
- Does the Code Address the Real Problem?
- Support for Continuing Medical Education
- Use of Prescription Data
- Formulary Committee Disclosure